CXCL5 acts as an oncogene and enhances cell growth and metastasis in several tumors, including bladder cancer, pancreatic cancer, cervical cancer, and cutaneous melanoma [24–27]. This evidence concerns the gene CXCL5 and urinary bladder carcinoma.